Navigation Links
Researcher finds altered cerebella in those with Down syndrome
Date:8/24/2011

AURORA, Colo. (Aug. 24, 2011) A scientist investigating why those with Down syndrome often have poor balance and motor coordination has found that key eye reflexes are substantially altered.

The findings by University of Colorado School of Medicine researcher Alberto Costa, MD, Ph.D., could lead to new tools to assess the effectiveness of new drugs and therapies aimed at improving quality of life for those with this genetic disorder.

"People with Down syndrome suffer various degrees of motor difficulty," said Costa, whose study was published last week in the journal, Experimental Brain Research. "They tend to walk later than their typical peers; they often lack balance and have low muscle tone and poor postural control."

That's likely because Down syndrome affects the optokinetic and vestibular systems of the brain. In a healthy brain, the vestibular system reacts to signals from neuroreceptors in the inner ear to produce responses to head movements. The optokinetic system uses visual information to produce eye movement. These reactions are often slow or decreased in those with Down syndrome.

Costa studied 32 participants between the ages of 14 and 36. He used special binocular goggles to measure eye movements in response to visual and vestibular stimuli. His focus was the cerebellum which is responsible for balance, posture and movement control.

"Although we have known for many years that the cerebellum is disproportionally shrunk in persons with Down syndrome, we wanted to find out how their cerebella operated on a functional level," Costa said. "We found that people with Down had much diminished optokinetic and vestibular reflexes compared to typically developing individuals. As a consequence, it is likely that things may appear blurry when they ride a bike or play sports."

Because those with Alzheimer's disease also show a similar reduction in the optokinetic reflex, these new findings further support Costa's ongoing exploration of the links between Down and Alzheimer's disease.

"All individuals with Down syndrome develop a neuropathology indistinguishable from Alzheimer's disease after the third decade of life," he said.

Babies born with Down often carry the biological markers for Alzheimer's. At the same time, 20-30 percent of those with Down syndrome develop full-blown Alzheimer's dementia by the time they reach their 50s, he said.

Costa recently completed a clinical trial with the drug Memantine used to treat Alzheimer's patients - to determine if it could boost memory and learning in those with Down syndrome. His work was chronicled in a lengthy New York Times Magazine profile earlier this month.

"Alzheimer's patients suffer similar declines to those with Down syndrome and we might be able to use the same drugs to treat both," he said. "As we continue to explore how these two conditions are linked, new avenues of treatment could arise that would not only alleviate symptoms but perhaps delay or stop the progression of these degenerative disorders."


'/>"/>

Contact: David Kelly
david.kelly@ucdenver.edu
303-315-6374
University of Colorado Denver
Source:Eurekalert

Related biology news :

1. UC Davis researchers find disease-causing fat cells in those with metabolic syndrome
2. Researchers uncover source of Haitian cholera outbreak
3. VBI, Convey Computer partner to deliver technology to biomedical, life sciences researchers
4. Cleveland researchers collaborate to launch Phase 1 clinical trial for new MS treatment
5. UT researchers develop algorithm to improve remote electrocardiography
6. TGen and DTU researchers track source of Haitian cholera outbreak
7. UH researchers explore treatments for breast and colon cancers
8. Not so fast -- researchers find that lasting evolutionary change takes about 1 million years
9. Joslin researchers identify new target for treatment of type 2 diabetes and prediabetes
10. Southampton researchers awarded $28 million to progress pioneering nutrition and respiratory research
11. Researchers on the trail of a treatment for cancer of the immune system
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/9/2016)... 2016  Perkotek an innovation leader in attendance control systems is proud to announce ... for employers to make sure the right employees are actually signing in, and to ... ... ... ...
(Date:6/2/2016)... The Department of Transport Management (DOTM) of ... Dollar project, for the , Supply and Delivery ... IT Infrastructure , to Decatur ... Identity Management Solutions. Numerous renowned international vendors participated in the ... was selected for the most compliant and innovative solution. The ...
(Date:5/24/2016)... superior patient care by providing unparalleled technology to leaders of the medical imaging industry. ... recently added to the range of products distributed by Ampronix. Photo - ... ... ... ...
Breaking Biology News(10 mins):
(Date:11/30/2016)... ... November 30, 2016 , ... ... Voice Coil Actuator with a flexure design that ensures high alignment accuracy by ... pricing and is ideally suited where extreme precision is required, such as in ...
(Date:11/30/2016)... Nov. 30, 2016  The Allen Institute for ... the first publicly available collection of gene edited, ... target key cellular structures with unprecedented clarity. Distributed ... powerful tools are a crucial first step toward ... understand what makes human cells healthy and what ...
(Date:11/30/2016)... Part of 5m$ Investment in Integrated ... ... LLC today announced that it had successfully completed the expansion ... have increased the Screening Collection to over 400,000. The new ... of the company. This expansion, complemented by new robotics and ...
(Date:11/30/2016)... Park, North Carolina (PRWEB) , ... November 30, 2016 , ... ... approved the names and symbols for four elements: nihonium (Nh), moscovium (Mc), tennessine ... a 5-month period of public review, the names earlier proposed by the discoverers have ...
Breaking Biology Technology: